| Exhibit |
|---|
| Number | Description |
| 3.1 | Restated Certificate of Incorporation filed April 12, 2024 (3) |
| 3.2. | Bylaws (5) |
| 4.1 | Form of Pre-Funded Warrant, dated May 21, 2024 (4) |
| 4.2 | Form of Common Warrant, dated May 21, 2024 (4) |
| 4.3 | Form of Pre-Funded Warrant, dated July 12, 2024 (6) |
| 4.4 | Form of Common Warrant, dated July 12, 2024 (6) |
| 10.1* | RRPV Base Agreement No. 2024-564, dated April 2, 2024, by and between GeoVax, Inc. and Advanced Technology International |
| 10.2* | RRPV Project Award No. 001, dated June 12, 2024, by and between Advanced Technology International (RRPV Consortium Management Firm) and GeoVax, Inc. (2) |
| 10.3 | Securities Purchase Agreement, dated May 16, 2024 (4) |
| 10.4 | Securities Purchase Agreement, dated July 11, 2024 (6) |
| 31.1* | Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934 |
| 31.2* | Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934 |
| 32.1* | Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002 |
| 32.2* | Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002 |
| 101.INS | Inline XBRL Instance Document (1) |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document (1) |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document (1) |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document (1) |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document (1) |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document (1) |
| 104 | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q and included in the Exhibit 101 Inline XBRL Document Set (1) |
| ** | Indicates a management contract or compensatory plan or arrangement |
|---|
| (1) | These interactive data files shall not be deemed filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under these sections. |
| (2) | Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit have been omitted as (i) the Company has determined the omitted information is not material and (ii) the Company customarily and actually treats the omitted information as private or confidential. |
| (3) | Incorporated by reference from the registrants Quarterly Report on Form 10-Q filed May 14, 2024. |
| (4) | Incorporated by reference from the registrant’s Current Report on Form 8-K filed May 21, 2024. |
| (5) | Incorporated by reference from the registrant’s Current Report on Form 8-K filed May 23, 2024. |
| (6) | Incorporated by reference from the registrant’s Current Report on Form 8-K filed July 12, 2024. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this quarterly report on Form 10-Q to be signed on its behalf by the undersigned thereunto duly authorized.
| GEOVAX LABS, INC. (Registrant) |
| Date: August 6, 2024 | By: | /s/ Mark W. Reynolds |
|---|
| Chief Financial Officer (duly authorized officer and principal financial officer) |
